Long‐Term Efficacy, Safety, and Tolerability of Alirocumab in 8242 Patients Eligible for 3 to 5 Years of Placebo‐Controlled Observation in the ODYSSEY OUTCOMES Trial

Goodman, Shaun G., Steg, Philippe Gabriel, Poulouin, Yann · Journal of the American Heart Association · 2023